Abstract:OBJECTIVE:To evaluate the effect of mucosal administration of altered collagen II(CII)263-272 peptide (267Q-->A, 270K-->A and 271G-->A) on collagen induced arthritis (CIA), and to explore the mechanism of the inhibitory effect of the altered CII263-272 peptide on CIA.METHODS:CIA was induced in Lewis rats by immunization with bovine CII. Altered CII263-272 peptide was given intranasally beginning from the onset of arthritis (100 microg/dose, daily for 5 doses and continuing every other day for other 7 doses). Wild CII263-272 peptide (100 microg/dose) or PBS was administered as controls with the same procedure. Therapeutic effects were evaluated by arthritis scores, body weight change, and joint pathologic scores. The anti-CII antibody and its subtypes were measured with ELISA. The cytokines of IFN-gamma and IL-10 were measured with ELISA. The induction of regulatory T cells was assessed by FACS analysis of percentage of peripheral CD4(+)CD25(+) T cells, and by real-time PCR analysis of the expression of Foxp3 and TGF-beta mRNA.RESULTS:(1) Following treatment with the altered CII263-272 peptide, arthritis scores were reduced and body weight was increased. The mean arthritis scores of rats treated with altered peptide, wild peptide and PBS were 2.50 +/- 2.43, 4.50 +/- 2.23 and 6.33 +/- 2.73, respectively. The altered peptide could retard the histologic lesion of the joints. (2) The titers of anti-CII antibodies IgG and IgG1 in the three groups were similar, but the IgG2a in altered peptide-treated rats decreased markedly as compared with PBS-treated rats (0.56 +/- 0.19 vs 0.95 +/- 0.29, P<0.05). The serum IFN-gamma in rats treated with altered peptide, wild peptide and PBS were (185.33 +/- 29.77), (231.62 +/- 41.82) and (220.64 +/- 83.61) ng/L, respectively (P<0.05). No difference was found in the levels of serum IL-10 among the three groups. (3) There was no significant difference in the percentage of peripheral CD4(+)CD25(+) T cells and the expression level of Foxp3 and TGF-beta mRNA.CONCLUSION:Mucosal administration of altered CII263-272 peptide could effectively inhibit the progression of CIA. It can decrease the IgG2a subtype of anti-CII antibodies and IFN-gamma, and inhibit Th1 response in vivo. Altered C II263-272 peptide may be therapeutic for RA.

Endogenous collagen peptide activation of CD1d-restricted NKT cells ameliorates tissue-specific inflammation in mice.

Collagen type II and a thermo-responsive polymer of N-isopropylacrylamide induce arthritis independent of Toll-like receptors: a strong influence by major histocompatibility complex class II and Ncf1 genes.

Collagen Type II and a Thermo-Responsive Polymer of N-Isopropylacrylamide Induce Arthritis Independent of Toll-Like Receptors

Type II Collagen in Cartilage Evokes Peptide-Specific Tolerance and Skews the Immune Response.

Collagen Epitope Expression on B Cells is Sufficient to Confer Tolerance to Collagen-Induced Arthritis

Analysis of Autoreactive T Cells Associated with Murine Collagen-Induced Arthritis Using Peptide-Mhc Multimers.

Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model.

Collagen Type II (Cii)-Specific Antibodies Induce Arthritis in the Absence of T or B Cells but the Arthritis Progression is Enhanced by CII-reactive T Cells

Mice Producing Less Reactive Oxygen Species Are Relatively Resistant to Collagen Glycopeptide Vaccination Against Arthritis

Polymorphonuclear Myeloid-Derived Suppressor Cells Play a Proinflammatory Role Via TNF-α+ B Cells Through BAFF/BTK/NF-κB Signalling Pathway in the Pathogenesis of Collagen-Induced Arthritis Mice

Analysis of type II collagen reactive T cells in the mouse. II. Different localization of immunodominant T cell epitopes on heterologous and autologous type II collagen.

T Cell Responses to a Non-Glycosylated Epitope Predominate in Type II Collagen-Immunised HLA-DRB1*0101 Transgenic Mice

Inhibition of Macropinocytosis Blocks Antigen Presentation of Type II Collagen in Vitro and in Vivo in HLA-DR1 Transgenic Mice

Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection.

Intrinsic Tolerance in Autologous Collagen-Induced Arthritis is Generated by CD152-Dependent CD4+ Suppressor Cells

Mucosal Administration of Altered CII263-272 Peptide Inhibits Collagen- Induced Arthritis

Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope.

T Cells Recognize A Glycopeptide Derived from Type Ii Collagen in A Model for Rheumatoid Arthritis

Induction of type II collagen expression in M2 macrophages derived from peripheral blood mononuclear cells

Regulation of T Cell Function by Reactive Nitrogen and Oxygen Species in Collagen-Induced Arthritis.

Systemic Versus Cartilage-Specific Expression Of A Type Ii Collagen-Specific T-Cell Epitope Determines The Level Of Tolerance And Susceptibility To Arthritis